Copyright
©The Author(s) 2020.
World J Gastroenterol. Feb 28, 2020; 26(8): 804-817
Published online Feb 28, 2020. doi: 10.3748/wjg.v26.i8.804
Published online Feb 28, 2020. doi: 10.3748/wjg.v26.i8.804
Figure 3 ORM expression is decreased in liver tumors.
A and B: The 369 liver tumor tissues, 160 cases of adjacent normal liver tissues and genotype tissue expression liver tissues were analyzed for orosomucoid 1 (ORM1) (A) and ORM2 (B) expression. C and D: The GSE36376 dataset was subjected to examination of ORM1 (C) and ORM2 (D) expression in 193 cases of normal liver tissues and 240 cases of liver tumor tissues. E and F: The GSE14520 dataset was subjected to examination of ORM1 (E) and ORM2 (F) expression in 220 cases of normal liver tissues and 225 cases of liver tumor tissues. cP < 0.001, tumor group compared with normal group. TPM: Transcript per million.
- Citation: Zhu HZ, Zhou WJ, Wan YF, Ge K, Lu J, Jia CK. Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer. World J Gastroenterol 2020; 26(8): 804-817
- URL: https://www.wjgnet.com/1007-9327/full/v26/i8/804.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i8.804